Introduction for Fucoxanthin powder
Tumors pose a serious threat to human health and quality of life, and their incidence is increasing year by year. Currently, surgery, radiotherapy (radiotherapy) and chemotherapy (chemotherapy) remain the primary means of treating cancer. Surgical treatment and radiation therapy are technically perfect, and it is difficult to significantly increase the cure rate. The increasing role of chemotherapy in comprehensive treatment and its increasing proportion have gradually become one of the most promising methods and methods for cancer treatment. Therefore, there is an urgent need to discover and develop new and effective anti-tumor drugs. At present, about 65% of anti-tumor drugs in European and American countries are derived from natural drugs, most of which are extracted from microorganisms or plants. With the continuous reduction of terrestrial biological resources, developed countries in the world have gradually shifted their focus to exploring new drug resources from marine organisms while developing terrestrial natural medicines and chemical synthetic drugs.
In recent years, with the continuous development of fucoxanthin powder, it has become one of the hotspots of marine drug research and development. In 1990, OKUZUMI et al reported that neuroblastoma cells were incubated with 10 μg·mL1 fucoxanthin powder, which reduced colonization by 62% after three days. Since then, several reports have reported anti-tumor pharmacological effects. Fucoxanthin powder may become a new nemesis of the tumor.
OKUZUMI and other studies have confirmed that fucoxanthin powder inhibits the activity of epirubic ornithine decarboxylase in mice induced by the strong skin cancer-producing substance tetradecanoylphorbol 13-acetate (TPA). It has an inhibitory effect on skin cancer. It was found by ESR signal strength analysis that it inhibited more than 50% of 12-DS and NB-L and 28% of DPPH production. The fucoxanthin effect can significantly inhibit the formation of skin cancer within 20 weeks, and the inhibition rate is 70%.
MASASHI et al. reported that fucoxanthin significantly inhibited the growth of colon cancer cell lines, including Caco2, HT29 and DLD1. MASASHI et al. reported the effect of Fucoxanthin powder on acute myeloid leukemia HL60 cell line. The results showed that fucoxanthin exerted a significant inhibitory effect on proliferation of HL60 cells. At the same time, studies have indicated that Fucoxanthin powder also has a certain degree of inhibition on prostate cancer, liver cancer, and vascular tumor cancer.
In recent years, marine medicine has been highly valued in cancer research, with a wide range of sources and small side effects, and has great potential as a new drug development. Both cell experiments and animal experiments have demonstrated that Fucoxanthin powder has good anti-tumor activity against a variety of tumors. For example, it can be used for the treatment and prevention of human tumors by intensive research on its target and mechanism of action.
Carton: 1kg with double plastic container inside/Aluminum foil bag outside;
25kg with double plastic container inside/Fiber drum outside.
or as customer’s requirement.
Suitable for ≤50kgs
Door to Door
Easy Pick Up Goods
Suitable for ≥50kgs
Airport to Airport
Pick Up Goods by Customer
Suitable for ≥500kgs
Port to Port
Pick Up Goods by Customer
Send your inquiry Details in the below for free sample, Click "Send" Now!